Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis

Sander van den Driesche, Christine L Mummery, Cornelius J J Westermann

Research output: Contribution to journalArticlepeer-review

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder in humans which has been mapped to two genes, endoglin and activin receptor-like kinase-1 (ALK-1) both of which mediate signaling by transforming growth factor beta ligands in vascular endothelial cells. Animal models have shown that these receptors are not only important for maintaining vascular integrity but also for angiogenesis both during embryonic development and during tumor growth. Here, we review the current status of reported mutations in the context of the clinical manifestations and the effects on the vessel wall both in patients and in animal models of the disease.

Original languageEnglish
Pages (from-to)20-31
Number of pages12
JournalCardiovascular Research
Volume58
Issue number1
Publication statusPublished - 1 Apr 2003

Keywords

  • Activin Receptors, Type I
  • Activin Receptors, Type II
  • Animals
  • Antigens, CD
  • Chromosomes, Human, Pair 12
  • Chromosomes, Human, Pair 9
  • Humans
  • Hypertension, Pulmonary
  • Mice
  • Mice, Mutant Strains
  • Mutation
  • Neovascularization, Pathologic
  • Receptors, Cell Surface
  • Signal Transduction
  • Telangiectasia, Hereditary Hemorrhagic
  • Transforming Growth Factor beta
  • Vascular Cell Adhesion Molecule-1
  • Zebrafish

Fingerprint

Dive into the research topics of 'Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis'. Together they form a unique fingerprint.

Cite this